Dr. François Jean

UBC LSI imaging facility

New nasal spray treats Delta variant infection in mice, indicating broad spectrum results

Researchers have shown a new compound delivered in a nasal spray is highly effective in preventing and treating COVID-19 caused by the Delta variant in mice.

Mar 28, 2022

Material coated in polymer in small scale tests with a green lamp. Credit: Taylor Wright

Futuristic coating for hospital fabrics and activewear kills COVID and E. coli

UBC researchers have developed an inexpensive, non-toxic coating for almost any fabric that decreases the infectivity of the virus that causes COVID-19 by up to 90 per cent.

Feb 10, 2022

SARS-CoV-2 B.1.1.7, also called the UK variant. The green depicts viral DsRNA and red shows viral nucleocapsid protein – these are both viral biomarkers, and indicate that the cell shown is infected by SARS-CoV-2. Credit: Dr. Guang Gao, UBC LSI IMAGING

Canadian researchers lead development and testing of promising treatment for COVID-19 variants

A new anti-viral drug could improve COVID-19 outcomes and survival rates — and is highly effective against multiple variants — according to a new study led by researchers at the University of British Columbia and Université de Sherbrooke.

May 11, 2021